Scientific Advisors

The scientific advisors for Celsion Corporation are world leaders in their respective fields. The value they bring in the area of basic research translation to clinical application cannot be overstated. Their contribution is a vital component of Celsion's strategic planning process.

David Cheresh PhD.

Chair for Research, Dept. of Pathology, UC San Diego.
Expert in Liposome/nanotechnology, angiogenesis, cell survival, integrins, signal transduction, tumor invasion, extracellular matrix.
http://cancer.ucsd.edu/Research/Summaries/dcheresh.asp

Peter Corry PhD.

Vice Chairman, Department of Radiation Oncology, University of Arkansas for Medical Sciences.
Expert in hyperthermia physics, tumor biology and clinical trials.
http://www.radonc.uams.edu/CorryP.asp

Mark Dewhirst DVM, PhD.

Professor of Radiation Oncology, Duke University Medical Center.
Expert in tumor hypoxia, angiogenesis and drug transport.
http://tml.duhs.duke.edu/

Wafik El-Deiry MD, PhD.

University of Pennsylvania. Professor, Departments of Medicine (Hematology/Oncology), Genetics, and Pharmacology.
Expert in molecular cancer biology, small molecule therapeutics, tumor suppressor genes and cell death signaling.
http://www.med.upenn.edu/camb/faculty/cgc/eldeiry.html

Jerry Glickson PhD.

Research Professor of Radiology, University of Pennsylvania School of Medicine.
Expert in Imaging of solid tumors.
http://www.uphs.upenn.edu/radiology/depa/researchLMI.shtml

Michael E. Weinblatt MD.

Co-Director, Clinical Rheumatology, Brigham and Women's Hospital, Professor of Medicine, Harvard Medical School.
Expert in therapeutics for rheumatoid arthritis.
(Web page is not available)